Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

October 2, 2024

Study Completion Date

October 2, 2024

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Magrolimab

Administered intravenously

DRUG

Pembrolizumab

Administered intravenously

DRUG

Docetaxel

Administered intravenously

DRUG

5-FU

Administered intravenously

DRUG

Cisplatin

Administered intravenously

DRUG

Carboplatin

Administered intravenously

DRUG

Zimberelimab

Administered intravenously

Trial Locations (88)

2010

St. Vincent's Hospital Sydney, Darlinghurst

2020

ZiekenhuisNetwerk Antwerpen (ZNA) - Stuivenberg, Antwerp

2109

Macquarie University, Macquarie Park

2145

Blacktown Hospital, Westmead

2650

UZ Antwerpen, Edegem

2781

Narodowy Instytut Onkologii im. M. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Glowy i Szyi, Warsaw

2800

AZ Sint-Maarten, Mechelen

2930

Algemeen Ziekenhuis Klina, Brasschaat

3000

Universitaire Ziekenhuis Leuven, Leuven

3004

Alfred Health, Melbourne

3084

Austin Health, Heidelberg

4102

Princess Alexandra Hospital, Woolloongabba

4103

Universitäres Krebszentrum Leipzig, Leipzig

4556

University of the Sunshine Coast, Sippy Downs

4870

Cairns Hospital, Cairns

5000

CHU UCL Namur - Sainte-Elisabeth, Namur

6189

Centre de Lutte Contre le Cancer (CLCC) - Centre Antoine Lacassagne (CAL) - Site Est, Nice

6800

Centre Hospitalizer De L'Ardenne, Libramont-Chevigny

8003

Hospital del Mar, Barcelona

8041

Hospital De La Santa Creu I Sant Pau, Barcelona

10029

Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital, New York

10177

Charite University Medicine, Berlin

11776

New York Cancer and Blood Specialists, Port Jefferson Station

13005

Hopital de la Timone, Marseille

17602

Lancaster General Hospital, Lancaster

20133

Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan

21079

Centre Georges François Leclerc, Dijon

22087

Kath. Marienkrankenhaus gGmbH, Hamburg

23007

Hospital Universitario de Jaen, Jaén

25123

ASST degli Spedali Civili di Brescia, Brescia

28007

Hospital General Universitario Gregorio Maranon, Madrid

28033

MD Anderson Cancer Center, Madrid

28046

Hospital Universitario La Paz, Madrid

29010

Hospital Regional Universitario de Malaga, Málaga

29425

Medical University of South Carolina, Charleston

30607

University Center and Blood Center,LLC., Athens

31008

Clinica Universidad de Navarra, Pamplona

33000

Institut Bergonie, Bordeaux

33021

Memorial Healthcare System, Hollywood

34471

Ocala Oncology Center, Ocala

37075

Universitatsmedizin Gottingen, GÃttingen

40138

Azienda Ospedaliero - Universitaria di Bologna - IRCCS, Bologna

41009

Hospital Universitario Virgen Macarena, Seville

41013

Hospital Universitario Virgen del Rocio, Seville

41124

Azienda Ospedaliero-Universitaria di Modena - Policlinico, Modena

42100

Arcispedale Santa Maria Nuova, Reggio Emilia

46026

Hospital Universitari i Politecnic La Fe, Valencia

46202

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

53100

Azienda Ospedaliero - Universitaria Senese, Siena

53127

Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III, Bonn

55100

Ospedale San Luca Luca, Lucca

55407

Virginia Piper Cancer Center (Alliant Health, Minneapolis

57105

Avera Cancer Institute, Sioux Falls

58122

Sanford Roger Maris Cancer Center, Fargo

63110

Washington University of Medicine- Siteman Cancer Center, St Louis

69310

Civils de Lyon-Centre Hopitalier Lyon Sud, Pierre-Bénite

69373

Centre Léon Bérard, Lyon

73104

OU Health Stephenson Cancer Center, Oklahoma City

75005

Institut Curie, Paris

75013

Hopital Pitie-Salpetriere, Paris

77030

MD Anderson Cancer Center, Houston

81675

Technische Universitat Munchen (TUM) - Klinikum Rechts der Isar, Munich

84112

Huntsman Cancer Institute, Salt Lake City

85224

Ironwood Cancer and Research Center, Chandler

90095

UCLA Hematology/Oncology, Los Angeles

90277

Torrance Memorial Physician Network - Cancer Care Associates, Redondo Beach

91010

City of Hope, Duarte

92151

Hopital Foch, Suresnes

94305

Stanford Cancer Institute, Palo Alto

94805

Institut Gustave Roussy, Villejuif

95403

Providence Medical Foundation, Santa Rosa

08816

Astera Cancer Care, East Brunswick

Unknown

Queen Mary Hospital, Hong Kong

Princess Margaret Hospital, Lai Chi Kok

Hospital Clínico Universitario de Valencia, Valencia

85-796

Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy, Bydgoszcz

44-102

Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie, Panstwowy Instytut Badawczy, Oddzial x Gliwicach, Gliwice

61-866

Wielkopolskie Centrum Onkologii im. Marii Sklodowskiej-Curie, Oddzial Onkologii Klinicznej i Immunookologii z Poddoddzialem Dziennym i Izba Przyjec, Poznan

08-110

Wojewodzki Szpital Specjalistyczny w Siedlcach, Siedlce

4710-243

Hospital de Braga, Braga

8000-366

Centro Hospitalar do Algarve, Faro

1998-018

Hospital CUF Descobertas, Lisbon

4464-513

Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA, Matosinhos Municipality

4050-011

Centro Hospitalar Universitario do Porto, Porto

4200-072

Instituto Portugues de Oncologia Do Porto Francisco Gentil,E.P.E., Porto

08035

Hospital Universitari Vall d'Hebron, Barcelona

SM2 5PT

Royal Marsden NHS Foundation Trust, Royal Marsden - Sutton, London

TA1 5DA

Musgrove Park Hospital, Taunton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT04854499 - Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter